NYSE:OGNPharmaceuticals
Organon (OGN) Is Up 8.4% After VTAMA Wins Key Steroid-Free Role In New Pediatric Guidelines
On April 15, 2026, Organon & Co. reported that VTAMA (tapinarof) cream received a strong, evidence-based recommendation in the American Academy of Dermatology’s first pediatric atopic dermatitis guidelines, which recognize it as the only steroid-free topical supported by high-certainty evidence for children aged 2 and older across all disease severities.
This endorsement strengthens VTAMA’s clinical profile in a large pediatric eczema population, potentially reinforcing Organon’s...